174 related articles for article (PubMed ID: 31283223)
1. Novel and Selective TLR7 Antagonists among the Imidazo[1,2-
Bou Karroum N; Moarbess G; Guichou JF; Bonnet PA; Patinote C; Bouharoun-Tayoun H; Chamat S; Cuq P; Diab-Assaf M; Kassab I; Deleuze-Masquefa C
J Med Chem; 2019 Aug; 62(15):7015-7031. PubMed ID: 31283223
[TBL] [Abstract][Full Text] [Related]
2. Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors.
Patinote C; Bou Karroum N; Moarbess G; Deleuze-Masquefa C; Hadj-Kaddour K; Cuq P; Diab-Assaf M; Kassab I; Bonnet PA
Eur J Med Chem; 2017 Sep; 138():909-919. PubMed ID: 28750313
[TBL] [Abstract][Full Text] [Related]
3. Selective Toll-like receptor 7 agonists with novel chromeno[3,4-d]imidazol-4(1H)-one and 2-(trifluoromethyl)quinoline/ quinazoline-4-amine scaffolds.
Dolšak A; Švajger U; Lešnik S; Konc J; Gobec S; Sova M
Eur J Med Chem; 2019 Oct; 179():109-122. PubMed ID: 31247373
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.
Naylor MA; Stephens MA; Nolan J; Sutton B; Tocher JH; Fielden EM; Adams GE; Stratford IJ
Anticancer Drug Des; 1993 Dec; 8(6):439-61. PubMed ID: 8286012
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor (TLR)-7 and -8 modulatory activities of dimeric imidazoquinolines.
Shukla NM; Mutz CA; Malladi SS; Warshakoon HJ; Balakrishna R; David SA
J Med Chem; 2012 Feb; 55(3):1106-16. PubMed ID: 22239408
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 7 and 8 imidazoquinoline-based agonist/antagonist pairs.
Yang M; Larson PG; Brown L; Schultz JR; Kucaba TA; Griffith TS; Ferguson DM
Bioorg Med Chem Lett; 2022 Mar; 59():128548. PubMed ID: 35051578
[TBL] [Abstract][Full Text] [Related]
7. Regioisomerism-dependent TLR7 agonism and antagonism in an imidazoquinoline.
Shukla NM; Kimbrell MR; Malladi SS; David SA
Bioorg Med Chem Lett; 2009 Apr; 19(8):2211-4. PubMed ID: 19285861
[TBL] [Abstract][Full Text] [Related]
8. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
[TBL] [Abstract][Full Text] [Related]
9. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
[TBL] [Abstract][Full Text] [Related]
10. Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity.
Parra S; Laurent F; Subra G; Deleuze-Masquefa C; Benezech V; Fabreguettes J; Vidal J; Pocock T; Elliott K; Small R; Escale R; Michel A; Chapat J; Bonnet P
Eur J Med Chem; 2001 Mar; 36(3):255-64. PubMed ID: 11337104
[TBL] [Abstract][Full Text] [Related]
11. Effective synthesis of benzimidazoles-imidazo[1,2-a]pyrazine conjugates: A comparative study of mono-and bis-benzimidazoles for antitumor activity.
Singh I; Luxami V; Paul K
Eur J Med Chem; 2019 Oct; 180():546-561. PubMed ID: 31344614
[TBL] [Abstract][Full Text] [Related]
12. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase.
Zhao F; Zhang J; Zhang L; Hao Y; Shi C; Xia G; Yu J; Liu Y
Bioorg Med Chem; 2016 Sep; 24(18):4281-4290. PubMed ID: 27448775
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
Moarbess G; Deleuze-Masquefa C; Bonnard V; Gayraud-Paniagua S; Vidal JR; Bressolle F; Pinguet F; Bonnet PA
Bioorg Med Chem; 2008 Jul; 16(13):6601-10. PubMed ID: 18513976
[TBL] [Abstract][Full Text] [Related]
15. Emergence of pyrido quinoxalines as new family of antimalarial agents.
Chandra Shekhar A; Shanthan Rao P; Narsaiah B; Allanki AD; Sijwali PS
Eur J Med Chem; 2014 Apr; 77():280-7. PubMed ID: 24650715
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
17. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
[TBL] [Abstract][Full Text] [Related]
18. Structure activity relationship studies of imidazo[1,2-a]pyrazine derivatives against cancer cell lines.
Myadaraboina S; Alla M; Saddanapu V; Bommena VR; Addlagatta A
Eur J Med Chem; 2010 Nov; 45(11):5208-16. PubMed ID: 20832916
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis reveals TLR7 dynamics underlying antagonism.
Tojo S; Zhang Z; Matsui H; Tahara M; Ikeguchi M; Kochi M; Kamada M; Shigematsu H; Tsutsumi A; Adachi N; Shibata T; Yamamoto M; Kikkawa M; Senda T; Isobe Y; Ohto U; Shimizu T
Nat Commun; 2020 Oct; 11(1):5204. PubMed ID: 33060576
[TBL] [Abstract][Full Text] [Related]
20. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
